|
|
|
|
|
by serf
1312 days ago
|
|
>..risks must necessarily be very low, as otherwise with a sample size of billions of doses issued even effects in the 1 in a million would be readily identifiable. it's by no means easy to identify trends that are worth pursuing for a medical investigation in a varied cohort of a billion people, and poll size is only a single attribute -- this is made even harder during a vacination campaign that is trying to effectively drive the un-vaccinated rates to as close to 0% as possible, making comparative studies even more difficult to establish. Time/race/status/age/health all matter. You can't just take a look at what conditions that the billions of vaccinated share, that's ineffective for any kind of impact study. It's my opinion that any 'precise' data is going to come about in years and years once we can establish a generational gap between this event and others so that we can effectively create a cross-generational comparative study. |
|
[1]: https://jamanetwork.com/journals/jama/fullarticle/2788346